Use of selenium to ameliorate doxorubicin induced hepatotoxicity by targeting pro-inflammatory cytokines

References

• Alshabanah OA, Hafez MM, Al-Harbi MM, Hassan ZK, Al Rejaie SS, Asiri YA, Sayed-Ahmed MM. 2010. Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxid Med Cell Longev. 3:428–433. doi:10.4161/oxim.3.6.14416
   PubMed Web of Science ®Google Scholar
• Ascensao A, Oliveira PJ, Magalhaes J. 2012. Exercise as a beneficial adjunct therapy during doxorubicin treatment–role of mitochondria in cardioprotection. Int J Cardiol. 156:4–10. doi:10.1016/j.ijcard.2011.05.060
   PubMed Web of Science ®Google Scholar
• Bardia A, Tleyjeh IM, Cerhan JR, Sood AK, Limburg PJ, Erwin PJ, Montori VM. 2008. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc. 83:23–34. doi:10.4065/83.1.23
   PubMed Web of Science ®Google Scholar
• Barogi S, Baracca A, Cavazzoni M, Parenti Castelli G, Lenaz G. 2000. Effect of the oxidative stress induced by adriamycin on rat hepatocyte bioenergetics during ageing. Mech Ageing Dev. 113:1–21. doi:10.1016/s0047-6374(99)00089-5
   PubMed Web of Science ®Google Scholar
• Bordoni A, Danesi F, Malaguti M, Di Nunzio M, Pasqui F, Maranesi M, Biagi PL. 2008. Dietary selenium for the counteraction of oxidative damage: fortified foods or supplements? Br J Nutr. 99:191–197. doi:10.1017/S0007114507793911
   PubMed Web of Science ®Google Scholar
• Bulucu F, Ocal R, Karadurmus N, Sahin M, Kenar L, Aydin A, Oktenli C, Koc B, Inal V, Yamanel L, Yaman H. 2009. Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity. Biol Trace Elem Res. 132:184–196. doi:10.1007/s12011-009-8377-y
   PubMed Web of Science ®Google Scholar
• Caglayan C, Temel Y, Kandemir FM, Yildirim S, Kucukler S. 2018. Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage. Env Sci Pollut Res Int. 25:20968–20984. doi:10.1007/s11356-018-2242-5
   PubMed Web of Science ®Google Scholar
• Coers W, Huitema S, van der Horst ML, Weening JJ. 1994. Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells. Exp Nephrol. 2:40–50.
   PubMedGoogle Scholar
• EI-Sayyad HI, Ismail MF, Shalaby FM, Abou-EI-Magd RF, Gaur RL, Fernando A, Raj MH, Ouhtit A. 2009. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci. 5:466–473. doi:10.7150/ijbs.5.466
   PubMed Web of Science ®Google Scholar
• Flora SJ, Kannan GM, Pant BP, Jaiswal DK. 2002. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide induced oxidative stress in rats. Arch Toxicol. 76:269–276. doi:10.1007/s00204-002-0347-5
   PubMed Web of Science ®Google Scholar
• Gao Y, Li X, Gao Q, Fan L, Jin H, Guo Y. 2019. Differential effects of olive oil, soybean oil, corn oil and lard oil on carbon tetrachloride-induced liver fibrosis in mice. Biosci Rep. 39:1–17. doi:10.1042/BSR20191913
   Web of Science ®Google Scholar
• Gewirtz DA. 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 57:727–741. doi:10.1016/s0006-2952(98)00307-4
   PubMed Web of Science ®Google Scholar
• Hellerbrand C. 2013. Hepatic stellate cells–the pericytes in the liver. Pflugers Arch. 465:775–778. doi:10.1007/s00424-012-1209-5
   PubMed Web of Science ®Google Scholar
• Huang Z, Rose AH, Hoffmann PR. 2012. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antiox Redox Sign. 16:705–743. doi:10.1089/ars.2011.4145
   PubMed Web of Science ®Google Scholar
• Hui H, Ma W, Cui J, Gong M, Wang Y, Zhang Y, He T, Bi Y, He Y. 2017. Periodic acid-Schiff staining method for function detection of liver cells is affected by 2% horse serum in induction medium. Mol Med Rep. 16:8062–8068. doi:10.3892/mmr.2017.7587
   PubMed Web of Science ®Google Scholar
• Ingawale DK, Mandlik SK, Naik SR. 2014. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Env Toxicol Pharmacol. 37:118–133. doi:10.1016/j.etap.2013.08.015
   PubMed Web of Science ®Google Scholar
• Jia X, Liu Q, Zou S, Xu X, Zhang L. 2015. Construction of selenium nanoparticles/beta-glucan composites for enhancement of the antitumor activity. Carbohydr Polym. 117:434–442. doi:10.1016/j.carbpol.2014.09.088
   PubMed Web of Science ®Google Scholar
• Jung HA, Kim JI, Choung SY, Choi JS. 2014. Protective effect of the edible brown alga Ecklonia stolonifera on doxorubicin‐induced hepatotoxicity in primary rat hepatocytes. J Pharm Pharmacol. 66:1180–1188. doi:10.1111/jphp.12241
   PubMed Web of Science ®Google Scholar
• Kart A, Cigremis Y, Karaman M, Ozen H. 2010. Caffeic acid phenethylester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Exp Toxicol Pathol. 62:45–52. doi:10.1016/j.etp.2009.02.066
   PubMed Web of Science ®Google Scholar
• Kong BH, Shin HD, Kim SH, Mok HS, Shim JK, Lee JH, Shin HJ, Huh YM, Kim EH, Park EK, Chang JH, Kim DS, Hong YK, Kim SH, Lee SJ, Kang SG. 2013. Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma. Int J Oncol. 42:1754–1762. doi:10.3892/ijo.2013.1856
   PubMed Web of Science ®Google Scholar
• Lance P, Alberts DS, Thompson PA, Fales L, Wang F, San Jose J, Jacobs ET, Goodman PJ, Darke AK, Yee M, Minasian L, Thompson IM, Roe DJ. 2017. Colorectal adenomas in participants of the SELECT randomized trial of selenium and vitamin E for prostate cancer prevention. Cancer Prev Res. 10:45–54. doi:10.1158/1940-6207.CAPR-16-0104
   PubMed Web of Science ®Google Scholar
• Lee HS, Jung KH, Hong SW, Park IS, Lee C, Han HK, Lee DH, Hong SS. 2008. Morin protects acute liver damage by carbon tetrachloride (CCl(4)) in rat. Arch Pharm. Res. (Seoul). 31:160–1165. doi:10.1007/s12272-001-1283-5
   PubMed Web of Science ®Google Scholar
• Lin W, Zheng L, Zhuang Q, Zhao J, Cao Z, Zeng J, Lin S, Xu W, Peng J. 2013. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway. BMC Comple Alt Med. 24:13:144. doi:10.1186/1472-6882-13-144.
   Web of Science ®Google Scholar
• Mansouri E, Jangaran A, Ashtari A. 2017. Protective effect of pravastatin on doxorubicin-induced hepatotoxicity. Bratisl Lek Listy. 118:273–277. doi:10.4149/BLL2017054
   PubMed Web of Science ®Google Scholar
• Martinet Lamas DJ, Nicoud MB, Sterle HA, Carabajal E, Tesan F, Perazzo JC, Rivera ES, Medina VA. 2015. Selective cytoprotective effect of histamine on doxorubicin induced hepatic and cardiac toxicity in animal models. Cell Death Discov. 1:150–159. doi:10.1038/cddiscovery.2015.59
   Web of Science ®Google Scholar
• Mazevet M, Moulin M, Llach-Martinez A, Chargari C, Deutsch E, Gomez AM, Morel E. 2013. Complications of chemotherapy, a basic science update. Presse Med. 42:352–361. doi:10.1016/j.lpm.2013.06.011
   PubMedGoogle Scholar
• Mete R, Oran M, Topcu B, Oznur M, Seber ES, Gedikbasi A, Yetisyigit T. 2016. Protective effects of onion (Allium cepa) extract against doxorubicin-induced hepatotoxicity in rats. Toxicol Ind Health. 32:551–557. doi:10.1177/0748233713504807
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. 2010. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 176:2–13. doi:10.2353/ajpath.2010.090675
   PubMed Web of Science ®Google Scholar
• Minoti G, Menna P, Salvatorelli E, Cairo G, Gianni L. 2004. Anthracyclines: molecular advances and pharmacologic development in antitumor activity and cardiotoxicity. Pharmacol Rev. 56:185–229. doi:10.1124/pr.56.2.6
   PubMed Web of Science ®Google Scholar
• Mocchegiani E, Costarelli L, Giacconi R, Malavolta M, Basso A, Piacenza F, Ostan R, Cevenini E, Gonos ES, Monti D. 2014. Micronutrient-gene interactions related to inflammatory/immune response and antioxidant activity in ageing and inflammation. A Systematic Review. Mech Ageing. Dev.137:29–49. doi:10.1016/j.mad.2013.12.007
   Google Scholar
• Mohan M, Kamble S, Satyanarayana J, Reddy N. 2011. Protective effect of Solanum torvum on doxorubicin-induced hepatotoxicity in rats. Int J Drug Dev. Res. 3:131–138. doi:10.1016/j.fct.2009.10.042
   Google Scholar
• Nagai K, Fukuno S, Oda A, Konishi H. 2016. Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses. Anticancer Drugs. 27:17–23. doi:10.1097/CAD.0000000000000299
   PubMed Web of Science ®Google Scholar
• Ognjanovic BI, Djordjevic NZ, Matic MM, Obradovic JM, Mladenovic JM, Stajn AS, Saicic ZS. 2012. Lipid peroxidative damage on cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Int J Mol Sci. 13:1790–1803. doi:10.3390/ijms13021790
   PubMed Web of Science ®Google Scholar
• Paczek L, Teschner M, Schaefer RM, Kovar J, Romen W, Heidland A. 1992. Intraglomerular proteinase activity in adriamycin-induced nephropathy. Nephron. 60:81–86. doi:10.1159/000186709
   PubMed Web of Science ®Google Scholar
• Patel N, Joseph C, Corcoran GB, Ray SD. 2010. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol. 245:143–152. doi:10.1016/j.taap.2010.02.002
   PubMed Web of Science ®Google Scholar
• Pereira GC, Pereira SP, Pereira CV, Lumini JA, Magalhaes J, Ascensao A, Santos MS, Moreno AJ, Olivera PJ. 2012. Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac specific. PLoS One. 7:e38867. doi:10.1371/journal.pone.0038867
   PubMed Web of Science ®Google Scholar
• Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, Sultana S. 2013. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol. Mech. Methods. 23:337–345. doi:10.3109/15376516.2012.759306
   PubMed Web of Science ®Google Scholar
• Rayman MP. 2002. The argument for increasing selenium intake. Proc Nutr Soc. 61:203–215. doi:10.1079/PNS2002153
   PubMed Web of Science ®Google Scholar
• Saad SY, Najjar TA, Al-Rikabi AC. 2001. The preventive role of deferoxamine against acute doxorubicin ınduced cardiac, renal and hepatic toxicity in rats. Pharmacol Res. 43:211–218. doi:10.1006/phrs.2000.0769
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Garcia EL, Prien SD, Tran RM, Feola M, Shires GT. 1995. Protective effect of selenium on hemoglobin mediated lipid peroxidation in vivo. Artif Cells Blood Subst Immobil Biotechnol. 23:469–486. doi:10.3109/10731199509117963.
   PubMed Web of Science ®Google Scholar
• Soudani N, Ben Amara I, Sefi M, Boudawara T, Zeghal N. 2011. Effects of selenium on chromium (VI)-induced hepatotoxicity in adult rats. Exp Toxicol Pathol. 63:541–548. doi:10.1016/j.etp.2010.04.005
   PubMedGoogle Scholar
• Stajn A, Zikic RV, Ognjanovic B, Saicic ZS, Pavlovic SZ, Kostic MM, Petrovic VM. 1997. Effect of cadmium and selenium on the antioxidant defence system in rat kidneys. Comp Biochem Physiol C. 117:167–172. doi:10.1016/s0742-8413(97)00063-7.
   PubMed Web of Science ®Google Scholar
• Stehbens WE. 2003. Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp Mol Pathol. 75:265–276. doi:10.1016/s0014-4800(03)00097-2
   PubMed Web of Science ®Google Scholar
• Stemm DN, Tharappel JC, Lehmler HJ, Srinivasan C, Morris JS, Spate VL, Robertson LW, Spear BT, Glauert HP. 2008. Effect of dietary selenium on the promotion of hepatocarcinogenesis by 3,3ʹ, 4,4ʹ-tetrachlorobiphenyl and 2,2ʹ, 4,4ʹ, 5,5ʹ-hexachlorobiphenyl. Exp Biol Med. 233:366–376. doi:10.3181/0708-RM-211
   PubMed Web of Science ®Google Scholar
• Supriya R, Tam BT, Pei XM, Lai CW, Chan LW, Yung BY, Siu PM. 2016. Doxorubicin induces inflammatory modulation and metabolic dysregulation in diabetic skeletal muscle. Front Physiol. 7:323–336. doi:10.3389/fphys.2016.00323
   PubMed Web of Science ®Google Scholar
• Tacar O, Sriamornsak P, Dass CR. 2013. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 65:157–170. doi:10.1111/j.2042-7158.2012.01567.x
   PubMed Web of Science ®Google Scholar
• Takahashi K, Newburger PE, Cohen HJ. 1986. Glutathione peroxidase protein. Absence in selenium deficiency states and correlation with enzymatic activity. J Clin Invest. 77:1402–1404. doi:10.1172/JCI112449
   PubMed Web of Science ®Google Scholar
• Tangpong J, Miriyala S, Noel T, Sinthubulyakit C, Jungsuwadee P, St. Clair DK. 2011. Doxorubicin induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neuroscience. 175:292–299. doi:10.1016/j.neuroscience.2010.11.007
   PubMed Web of Science ®Google Scholar
• Zhang Q, Chen L, Guo K, Zheng L, Liu B, Yu W, Guo C, Liu Z, Chen Y, Tang Z. 2013. Effects of different selenium levels on gene expression of a subset of selenoproteins and antioxidative capacity in mice. Biol Trace Elem Res. 154:255–261. doi:10.1007/s12011-013-9710-z
   PubMed Web of Science ®Google Scholar